Annexon, Inc.

Historical 13F Holders

Symbol
ANNX
CUSIP
03589W102
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 03589W102 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G/A
13.9% 11/5/2026
Event 9/30/2026
Redmile Group, LLC 13G/A
9.9% 7/8/2026
Event 7/1/2026
BlackRock, Inc. 13G/A 8.0% 7/27/2026
Event 6/30/2026
Satter Muneer A 13D/A 7.2% 11/21/2025
Event 11/19/2025
State Street Corp 13G 6.0% 8/7/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
Bain Capital Life Sciences Fund, L.P. 13G/A
4.9% 2/14/2025
Event 12/31/2024
Biotechnology Value Fund L P 13G/A
4.4% 11/16/2026
Event 9/30/2026
Point72 Asset Management, L.P. 13G/A
0.1% 5/15/2025
Event 3/31/2025
Logos Global Management LP 13G/A
0% 8/14/2025
Event 6/30/2025
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 211 196 M $830M
2026 Q2 218 178 M $1.02B
2026 Q1 219 156 M $865M
2025 Q4 168 137 M $687M
2025 Q3 144 101 M $309M
2025 Q2 130 99.7 M $239M
2025 Q1 150 99.8 M $192M
2024 Q4 154 112 M $575M
2024 Q3 144 110 M $651M
2024 Q2 145 108 M $527M
2024 Q1 131 95.0 M $680M
2023 Q4 102 80.8 M $366M
2023 Q3 95 53.6 M $126M
2023 Q2 97 54.1 M $190M
2023 Q1 102 54.0 M $208M
2022 Q4 87 48.5 M $244M
2022 Q3 74 47.6 M $292M
2022 Q2 80 38.4 M $145M
2022 Q1 104 39.0 M $107M
2021 Q4 100 38.8 M $446M
2021 Q3 84 38.1 M $709M
2021 Q2 76 38.9 M $874M
2021 Q1 74 37.4 M $1.04B
2020 Q4 72 36.2 M $904M
2020 Q3 68 34.8 M $1.04B